Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Standard
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms. / Janson, Eva Tiensuu; Sorbye, Halfdan; Welin, Staffan; Federspiel, Birgitte; Grønbæk, Henning; Hellman, Per; Ladekarl, Morten; Langer, Seppo W; Mortensen, Jann; Schalin-Jäntti, Camilla; Sundin, Anders; Sundlöv, Anna; Thiis-Evensen, Espen; Knigge, Ulrich.
I: Acta Oncologica, Bind 53, Nr. 10, 2014, s. 1284-1297.Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
AU - Janson, Eva Tiensuu
AU - Sorbye, Halfdan
AU - Welin, Staffan
AU - Federspiel, Birgitte
AU - Grønbæk, Henning
AU - Hellman, Per
AU - Ladekarl, Morten
AU - Langer, Seppo W
AU - Mortensen, Jann
AU - Schalin-Jäntti, Camilla
AU - Sundin, Anders
AU - Sundlöv, Anna
AU - Thiis-Evensen, Espen
AU - Knigge, Ulrich
PY - 2014
Y1 - 2014
N2 - BACKGROUND: The diagnostic work-up and treatment of patients with neuroendocrine neoplasms (NENs) has undergone major recent advances and new methods are currently introduced into the clinic. An update of the WHO classification has resulted in a new nomenclature dividing NENs into neuroendocrine tumours (NETs) including G1 (Ki67 index ≤ 2%) and G2 (Ki67 index 3-20%) tumours and neuroendocrine carcinomas (NECs) with Ki67 index > 20%, G3. Aim. These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients.
AB - BACKGROUND: The diagnostic work-up and treatment of patients with neuroendocrine neoplasms (NENs) has undergone major recent advances and new methods are currently introduced into the clinic. An update of the WHO classification has resulted in a new nomenclature dividing NENs into neuroendocrine tumours (NETs) including G1 (Ki67 index ≤ 2%) and G2 (Ki67 index 3-20%) tumours and neuroendocrine carcinomas (NECs) with Ki67 index > 20%, G3. Aim. These Nordic guidelines summarise the Nordic Neuroendocrine Tumour Group's current view on how to diagnose and treat NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients.
KW - Antineoplastic Agents
KW - Carcinoma, Neuroendocrine
KW - Diagnostic Imaging
KW - Gastrointestinal Neoplasms
KW - Humans
KW - Liver Neoplasms
KW - Neuroendocrine Tumors
KW - Pancreatic Neoplasms
KW - Prognosis
KW - Tumor Markers, Biological
U2 - 10.3109/0284186X.2014.941999
DO - 10.3109/0284186X.2014.941999
M3 - Review
C2 - 25140861
VL - 53
SP - 1284
EP - 1297
JO - Acta Oncologica
JF - Acta Oncologica
SN - 1100-1704
IS - 10
ER -
ID: 137619541